(ICCC)

Role: VP of Sales and Marketing, Director
Signature: /s/ Timothy C. Fiori Attorney-in-Fact
Issuer symbol: ICCC
Transactions as of: 27 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 29 Jan 2026, 11:42:02 UTC
Previous filing: 09 Feb 2022
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Brockmann Bobbi Jo	VP of Sales and Marketing, Director	C/O IMMUCELL CORPORATION, 56 EVERGREEN DRIVE, PORTLAND	/s/ Timothy C. Fiori Attorney-in-Fact	29 Jan 2026	0001517536

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ICCC	Stock Options (right to buy)	Award	$0	+100,000		$0.000000	100,000	27 Jan 2026	Common Stock	100,000	$6.26	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Option grant made to Ms. Brockmann in connection with her employment as Vice President of Sales and Marketing. The option shall be treated as an incentive stock option to the maximum extent permitted by the Internal Revenue Code of 1986, as amended, with the balance treated as a nonqualified stock option. The stock option vests as follows: 33,333 shares becoming exercisable on each of January 27, 2027 and January 27, 2028 and 33,334 shares becoming exercisable on January 27, 2029.

Content

Option grant made to Ms. Brockmann in connection with her employment as Vice President of Sales and Marketing. The option shall be treated as an incentive stock option to the maximum extent permitted by the Internal Revenue Code of 1986, as amended, with the balance treated as a nonqualified stock option. The stock option vests as follows: 33,333 shares becoming exercisable on each of January 27, 2027 and January 27, 2028 and 33,334 shares becoming exercisable on January 27, 2029.